- Report
- May 2023
- 140 Pages
Global
From €4504EUR$4,949USD£3,861GBP
- Report
- December 2023
- 250 Pages
Global
€4546EUR$4,995USD£3,897GBP
- Report
- November 2019
Global
From €9096EUR$9,995USD£7,798GBP
- Report
- November 2024
- 78 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- October 2024
- 95 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- October 2024
- 107 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- October 2023
- 146 Pages
Global
From €3777EUR$4,150USD£3,238GBP
- Report
- February 2022
- 172 Pages
Global
From €3378EUR$3,712USD£2,896GBP
- Report
- May 2022
- 210 Pages
Global
From €3145EUR$3,456USD£2,696GBP
The Wearable Cardioverter Defibrillator (WCD) is a type of cardiovascular device used to detect and treat life-threatening arrhythmias. It is worn on the body and is designed to detect and treat ventricular tachycardia and ventricular fibrillation. The device is typically used in patients who are at risk of sudden cardiac arrest, such as those with a history of heart failure or a previous cardiac arrest. It is also used in patients who have had an implantable cardioverter defibrillator (ICD) removed due to complications.
The WCD market is growing due to the increasing prevalence of cardiovascular diseases and the need for improved patient care. The device is also becoming more widely accepted due to its convenience and safety. Additionally, technological advancements have enabled the device to be more accurate and reliable.
Some of the major players in the WCD market include Medtronic, Abbott, Boston Scientific, Biotronik, and Zoll Medical. Show Less Read more